Legal Representation
Attorney
William S. Frommer, Esq.
USPTO Deadlines
Application History
49 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 15, 2012 | MAB3 | O | ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL | Loading... |
| Feb 22, 2012 | ABN3 | O | ABANDONMENT - AFTER EX PARTE APPEAL | Loading... |
| Feb 22, 2012 | EXPT | T | EXPARTE APPEAL TERMINATED | Loading... |
| Jan 4, 2012 | EXFB | T | EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF | Loading... |
| Oct 21, 2011 | GEA1 | O | NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED | Loading... |
| Oct 21, 2011 | GECD | O | ACTION DENYING REQ FOR RECON E-MAILED | Loading... |
| Oct 21, 2011 | CNCF | W | SU - ACTION CONTINUING FINAL - WRITTEN | Loading... |
| Sep 28, 2011 | EXPI | T | EX PARTE APPEAL-INSTITUTED | Loading... |
| Sep 28, 2011 | JURT | T | JURISDICTION RESTORED TO EXAMINING ATTORNEY | Loading... |
| Sep 28, 2011 | EXAF | T | EXPARTE APPEAL RECEIVED AT TTAB | Loading... |
| Sep 26, 2011 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 26, 2011 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 26, 2011 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Mar 31, 2011 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Mar 31, 2011 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Mar 31, 2011 | CNFR | W | SU - FINAL REFUSAL - WRITTEN | Loading... |
| Mar 7, 2011 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED | Loading... |
| Mar 7, 2011 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 28, 2011 | I | PAPER RECEIVED | Loading... | |
| Jan 6, 2011 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 25, 2010 | DMCC | I | DATA MODIFICATION COMPLETED | Loading... |
| Aug 25, 2010 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Aug 25, 2010 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 25, 2010 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 25, 2010 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... |
| Aug 6, 2010 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 5, 2010 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Jul 6, 2010 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Aug 5, 2010 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jul 6, 2010 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Aug 5, 2010 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jul 6, 2010 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 6, 2010 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Dec 15, 2009 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Dec 15, 2009 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Dec 15, 2009 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 7, 2009 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 14, 2009 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 25, 2009 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Mar 9, 2009 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Mar 9, 2009 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Mar 6, 2009 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 6, 2009 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Mar 6, 2009 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 6, 2009 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 6, 2009 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Mar 6, 2009 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 12, 2008 | MDSC | O | NOTICE OF DESIGN SEARCH CODE MAILED | Loading... |
| Dec 11, 2008 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
pharmaceutical preparations for use in oncology, endoctrinology, neurology, hematology, gastroenterology, cardiovascular and cognitive disorders
First Use Anywhere:
Nov 1, 2007
First Use in Commerce:
Nov 1, 2007
Additional Information
Design Mark
The mark consists of the color dark blue appears in the wording "IPSEN INNOVATION FOR PATIENT CARE" and the S-shaped curved line in the design and the color light blue appears in the two smaller curved lines and the dot in the design.
Color Claim
The color(s) dark blue and light blue is/are claimed as a feature of the mark.
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PATIENT CARE"